| Literature DB >> 24450835 |
Angelika Agdestein, Anya Jones, Arnar Flatberg, Tone B Johansen, Inger Austrheim Heffernan, Berit Djønne, Anthony Bosco, Ingrid Olsen1.
Abstract
BACKGROUND: Mycobacterium avium subsp. avium (Maa) and M. avium subsp. hominissuis (Mah) are environmental mycobacteria and significant opportunistic pathogens. Mycobacterium avium infections in humans and pigs are mainly due to Mah. It is not known whether this is caused by a difference in virulence or difference in exposure to the two subspecies. The aim of the present study was to investigate the ability of the M. avium subspecies to replicate intracellularly and to characterise the gene expression program triggered by infection of human primary macrophages.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24450835 PMCID: PMC3906092 DOI: 10.1186/1471-2164-15-58
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Characteristics of isolates used in the present study
| Porcine | + | - | + | - | ||
| Porcine | - | + | - | - | ||
| Human | - | - | + | - | ||
| Human | - | - | + | + | ||
| Avian | - | - | + | + | ||
| Avian | - | - | + | + |
Isolates of Mycobacterium avium used in the present study show different combinations of subspecies designation, origin, biofilm abilities and the genomic presence of ISMpa1 and genes involved in the synthesis of non-specific (ns) or serovar specific (ss) GPLs [12].
Figure 1Uptake of six clinical isolates of in human CD14+ cells. Cells were inoculated for three, six, 12 and 24 hours. Numbers represent the mean values from three donors, showing the ratio of numbers of mycobacterial to human genomes (A) and absolute numbers of mycobacteria per well (B), measured by real-time PCR of single copy genes in cell lysates.
Figure 2Intracellular replication of six clinical isolates of in human CD14+ cells. Sampling was performed after six hours of inoculation with added bacteria, then one, four and seven days after removal of extracellular bacteria. Numbers represent the mean values from six donors, showing the ratio of numbers of mycobacterial to human genomes (A) and absolute numbers of mycobacteria per well (B), measured by real-time PCR of single copy genes in cell lysates. There was a significant increase in the ratio of mycobacteria at day four for isolate Maa 1794 (p = 0.04) and at day 7 for Maa1794 (p = 0.01) and Maa 1553 (p = 0.02) and in absolute numbers of bacteria for isolate Maa 1794 (p = 0.01) at day 7 using the paired t-test.
Figure 3Numbers of differentially expressed genes in human macrophages infected with different isolates of The Venn diagrams of numbers of up-regulated (A) and down-regulated (B) genes show unique and common differential expression of transcripts in human macrophages in response to four hours of incubation by three different isolates of Mycobacterium avium. Maa 1794 is an intracellularly replicating isolate of M. avium subsp. avium, whereas Mah VI101 and Mah 1655 are isolates of M. avium subsp. hominissuis that only invade and persist within cells.
Analysis of biological functions induced infection of human monocyte-derived macrophages with isolates
| Negative regulation of apoptosis | 15.2 | |
| | Inflammatory response | 13.5 |
| | Induction of apoptosis | 12.7 |
| | Cytokine/chemokine activity | 8.4 |
| | Regulation of cytokine production | 7.1 |
| | Regulation of signal transduction | 6.6 |
| | Regulation of T and B cell activation/proliferation | 6.0 |
| | Regulation of protein cytokine secretion | 5.2 |
| | Regulation of phosphorylation | 4.8 |
| | Response to molecule of bacterial origin | 3.8 |
| Inflammatory response | 15.5 | |
| | Negative regulation of apoptosis | 9.8 |
| | Induction of apoptosis | 6.6 |
| | Cytokine/chemokine activity | 5.9 |
| | Regulation of T and B cell activation/proliferation | 4.5 |
| | Regulation of phosphorylation | 4.2 |
| | Response to molecule of bacterial origin | 4.1 |
| | Regulation of viral replication | 3.6 |
| | Pattern recognition receptor pathway signalling | 3.5 |
| | Cell migration | 3.5 |
| Inflammatory response | 16.5 | |
| | Negative regulation of apoptosis | 14.2 |
| | Induction of apoptosis | 13.0 |
| | Response to molecule of bacterial origin | 8.3 |
| | Regulation of signal transduction | 8.2 |
| | Cytokine/chemokine activity | 7.6 |
| | Regulation of T and B cell activation/proliferation | 6.6 |
| | Regulation of cytokine production | 6.0 |
| | Regulation of protein cytokine secretion | 4.9 |
| Regulation of phosphorylation | 4.3 |
The analysis was done using the Database for Annotation, Visualization and Integrated Discovery (DAVID). An Enrichment score > 1.3 was considered statistically significant.
Canonical pathway analyses
| TNFR2 signaling | 6.3E-14 | |
| | Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis | 5.0E-11 |
| | Death receptor signaling | 5.0E-11 |
| | Regulation of cytokine production in macrophages and Th cells by IL-17A and IL-17 F | 6.3E-11 |
| | Role of IL-17A in arthritis | 1.9E-10 |
| | TNFR1 signaling | 2.8E-10 |
| | TREM1 signaling | 7.6E-10 |
| | Regulation of cytokine production in intestinal epithelial cells by IL-17A and IL-17 F | 1.4E-09 |
| | Hepatic fibrosis/Hepatic stellate cell activation | 1.7E-09 |
| | IL-6 signaling | 1.9E-09 |
| TNFR2 signaling | 6.3E-12 | |
| | 4-1BB signaling in T lymphocytes | 7.2E-10 |
| | TNFR1 signaling | 1.1E-09 |
| | Small cell lung cancer signaling | 2.9E-09 |
| | Role of IL-17A in arthritis | 4.0E-09 |
| | Death receptor signaling | 7.6E-09 |
| | Induction of apoptosis by HIV1 | 8.9E-09 |
| | iNOS signaling | 1.4E-08 |
| | Type I diabetes mellitus signaling | 1.5E-08 |
| | Regulation of cytokine production in macrophages and Th cells by IL-17A and IL-17 F | 1.9E-08 |
| Death receptor signaling | 1.0E-13 | |
| | TNFR2 signaling | 1.0E-12 |
| | Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis | 2.5E-11 |
| | Small cell lung cancer signaling | 6.3E-11 |
| | Role of IL-17 F in allergic inflammatory airway diseases | 1.4E-10 |
| | TWEAK signaling | 3.0E-10 |
| | Role of IL-17A in arthritis | 3.7E-10 |
| | TNFR1 signaling | 4.1E-10 |
| | Regulation of cytokine production in macrophages and Th cells by IL-17A and IL-17 F | 5.1E-10 |
| | IL-17A Signaling in fibroblasts | 7.1E-10 |
| | ||
| Role of CHK proteins in cell cycle checkpoint control | 1.2E-04 | |
| | Tetrapyrrole biosynthesis II | 1.9E-04 |
| | Galactose degradation I (Leloir pathway) | 1.9E-04 |
| | Mismatch repair in Eukaryotes | 7.8E-04 |
| | Heparan sulfate biosynthesis | 8.1E-04 |
| | Role of BRCA1 in DNA damage response | 1.2E-03 |
| | Heme biosynthesis II | 1.5E-03 |
| | Glycine betaine degradation | 2.1E-03 |
| | Coenzyme A biosynthesis | 2.2E-03 |
| | L-serine degradation | 2.2E-03 |
| Colorectal cancer metastasis signaling | 4.4E-04 | |
| | Hereditary breast cancer signaling | 1.3E-03 |
| | Role of BRCA1 in DNA damage response | 1.9E-03 |
| | IL-12 signaling and production in macrophages | 2.2E-03 |
| | Sulfite oxidation IV | 4.2E-03 |
| | Antiproliferative role of TOB in T cell signaling | 5.1E-03 |
| | Dendritic cell maturation | 6.0E-03 |
| | Role of NFAT in cardiac hypertrophy | 6.5E-03 |
| | HMGB1 signaling | 6.6E-03 |
| | Superpathway of inositol phosphate compounds | 6.9E-03 |
| Mismatch repair in Eukaryotes | 6.3E-07 | |
| | Role of BRCA1 in DNA damage response | 2.9E-06 |
| | CHK proteins in cell cycle checkpoint control | 5.6E-06 |
| | CTLA4 signaling in cytotoxic T lymphocytes | 7.9E-06 |
| | Hereditary breast cancer signaling | 1.5E-05 |
| | Growth hormone signaling | 1.7E-05 |
| | Molecular mechanisms of cancer | 1.7E-05 |
| | ERK5 signaling | 2.7E-05 |
| | Production of NO amd ROS in macrophages | 3.8E-05 |
| B cell receptor signaling | 1.3E-04 |
Pathways induced by infection of human monocyte-derived macrophages with M. avium isolates.
The analysis was done in Ingenuity Systems software.
The ten top pathways are shown.
Upstream regulator analyses
| TNF | 12.15 | 1.40E-76 | |
| | NFkB (complex) | 9.02 | 1.14E-60 |
| | IL1B | 9.32 | 9.77E-58 |
| | CD40LG | 6.34 | 2.80E-56 |
| | TREM1 | 2.56 | 2.45E-49 |
| | IFNG | 7.68 | 2.73E-42 |
| | RELA | 6.59 | 3.37E-42 |
| | TNFSF11 | 6.16 | 5.99E-41 |
| | NFKBIA | 4.12 | 8.41E-40 |
| | IKBKB | 5.41 | 2.25E-35 |
| TNF | 8.45 | 2.79E-58 | |
| | NFkB (complex) | 6.45 | 1.57E-42 |
| | CD40LG | 4.03 | 5.71E-39 |
| | IL1B | 6.52 | 8.67E-39 |
| | IL1A | 4.97 | 1.08E-27 |
| | TNFSF11 | 4.30 | 1.12E-27 |
| | RELA | 5.07 | 4.74E-27 |
| | IFNG | 5.50 | 1.72E-26 |
| | NFKBIA | 2.86 | 2.75E-26 |
| | TREM1 | 2.18 | 2.80E-26 |
| TNF | 12.36 | 6.80E-70 | |
| | NFkB (complex) | 9.52 | 6.86E-63 |
| | CD40LG | 6.40 | 2.02E-55 |
| | IL1B | 9.70 | 7.41E-52 |
| | IFNG | 8.72 | 8.88E-44 |
| | NFKBIA | 3.01 | 1.96E-39 |
| | RELA | 6.92 | 2.09E-37 |
| | TNFSF11 | 6.55 | 3.60E-37 |
| | TLR4 | 6.58 | 5.10E-36 |
| IL1A | 7.19 | 7.30E-36 |
Genes predicted to act as up-stream regulators for the observed responses after infection of human monocyte-derived macrophages with M. avium isolates.
The analysis was done in Ingenuity Systems software. Responses to chemicals/drugs are excluded. The ten top genes are shown.
Figure 4Gene networks triggered in human macrophages infected with different isolates of Cells have been incubated with M. avium subsp. avium 1794 (A), M. avium subsp. hominissuis VI101 (B) and M. avium subsp. hominissuis 1655 (C) for four hours. Blue hubs indicate up-regulation, yellow indicate down-regulation of the respective gene. The size of the gene name reflects the number of links to other genes in the network, and genes with < 5 genes are minimized. For this analysis the number of genes was reduced, in order to comply with the limitation of the IPA software, by increasing the stringency of the statistical analysis to FDR < 0.01 from FDR < 0.05.
Top 20 hub genes and number of connections induced by infection of human monocyte-derived macrophages with isolates
| TNF | 61 | TNF | 178 | TNF | 219 |
| IL1B | 43 | IL6 | 117 | IL6 | 141 |
| IL6 | 38 | IL1B | 113 | IL1B | 127 |
| NFKBIA | 34 | NFKBIA | 81 | NFKBIA | 93 |
| NFKB1 | 27 | IL10 | 80 | FOS | 88 |
| IL1A | 22 | NFKB1 | 70 | NFKB1 | 76 |
| PTGS2 | 19 | FOS | 69 | CSF2 | 66 |
| NFKB2 | 18 | CSF2 | 59 | ILIA | 63 |
| CXCL2 | 18 | ILIA | 58 | BCL2 | 59 |
| CCL5 | 18 | JUN | 57 | OSM | 59 |
| OSM | 17 | CD40 | 53 | CD40 | 58 |
| TNFAIP3 | 14 | PTGS2 | 52 | PTGS2 | 56 |
| CCL3L1 | 14 | Rb1 | 50 | SRC | 55 |
| LIF | 14 | BCL2 | 47 | RB1 | 50 |
| CCL20 | 14 | OSM | 47 | IL15 | 50 |
| REL | 13 | VEGFA | 46 | CXCL2 | 45 |
| SOD2 | 13 | SRC | 43 | CCL5 | 42 |
| NFKBIB | 11 | CCL5 | 42 | PIK3R1 | 42 |
| CCL3 | 11 | CXCL2 | 42 | CEBPA | 41 |
| TRAF1 | 10 | NFKB2 | 38 | TICAM1 | 41 |
Figure 5Cytokine expression from primary monocyte-derived macrophages. CD14+ cells were obtained from six donors and allowed to mature into macrophages by incubation for five days. The cells were then infected with the three isolates, Maa 1794, Mah 1655 and Mah VI101, at a MOI of 10:1 for 24 hours or left uninfected (neg). The supernatant was removed and assessed for IL-6, IL-8, IL-10, IL-23 and TNF-α by the Bio-plex assay. The six donors are represented with individual symbols. Each point is the median of triplicate wells. The horizontal line represents the mean response of the six donors. Mah VI101, consistently produced more IL-8, IL-23 and TNF-α than Maa 1794 and more IL-23 than Mah 1655. The difference was significant (p < 0.05) using the non-parametric Wilcoxon signed rank test.